
This episode we look at some of the latest compounding news, and then we’ve got a deep dive into state-level legislation with the Leading Ladies of Pharmacy Compounding Advocacy. What bills are being introduced? What do they really mean when you read the detail? How will they affect state policies, and what could come next? And, of course, how are APC and compounding pharmacies fighting back against the bad bills that put patients at risk? If you’re a compounder, if you have patients who use compounded medications, or if you’re a patient yourself, you’ll want to hear this. Links from the podcast: The FDA statement on excluding GLP-1s from bulk compounding: https://fllw.me/491oGl3 FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C (part 1), https://fllw.me/4nxd13G (part 2) Is It Legit? to find a state-licensed compounding pharmacy: https://a4pc.org/isitlegit Join APC! https://a4pc.org/join
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Asembia's Specialty Pharmacy Summit Rewind 2026 | 6/6

Birth Rights, Medical Bills & Legal Advocacy with Andi Orwoll, Esq. | MaternalRx

Why the Pharmacy Supply Chain Breaks — and What Leaders Must Do About It | Executive Dose

Transparency, Auditing, and the PBM Shell Game | PBM Reform Podcast
Free AI-powered recaps of Pharmacy Podcast Network and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.